>>On the Market

Healthcare Professionals: Please visit the Aggrastat product website.

>>In Development

Medicure is currently developing a transdermal delivery formulation of its lead drug
AGGRASTAT (tirofiban HCl).
Read more..

>>Latest News

Septembert 10, 2014
Medicure Reports Financial Results For Fiscal 2014 Read more

August 13, 2014
Medicure Provies Updates on Tardoxal and TEND-TD Study Read more

July 11, 2014
Medicure Announces Shares for Debt Settlement Read more

Sign up to receive email updates such as Press Release nofications and other company news.

>>Clinical Trials

SAVI-PCI
Read more on clinicaltrials.gov

TEND TD
Read more on clinicaltrials.gov

>>A Heart for Life

Medicure is a specialty pharmaceutical company engaged in the research, clinical development and commercialization of human
therapeutics. Find out more.